CARLSBAD, Calif., May 1, 2008 --(BUSINESS WIRE)--More than 1,500 employees of Invitrogen Corporation (NASDAQ:IVGN - News), a provider of essential life science technologies for research, production and diagnostics, today donated a half day of their time to dozens of projects around the globe as part of the Company’s 5th Annual Global Volunteer Day. More than 6,000 hours of total volunteer time were donated to activities in more than 20 countries.

Some of the projects included:

• Clearing out more invasive species from Batiquitos Lagoon in Carlsbad, California
• Performing ground maintenance for the Science Factory in Eugene, Oregon to help the museum prepare for summer camp season.
• Giving elementary school children in Camarillo, California a jump start in environmental education by building a garden for the school filled with native California plants
• Beautifying a park area near Niagara Falls, in Grand Island, New York
• Blood and bone marrow drive at Japan’s Tokyo Dome during a Yomiuri Giants baseball game
• Clearing one of the oldest natural woods areas in Glasgow, Scotland, home to a rare butterfly
• Host a local holiday festival with 120 new immigrant children and their parents in Ethrog, Israel
• Cleaning the Auckland City Mission in New Zealand.

On Global Volunteer Day, Invitrogen, a provider of essential life science technologies for research, production and diagnostics, provides each of its 4,700 employees with five hours of paid time to participate in volunteer projects.

“Over the past five years, Global Volunteer Day has become an important part of Invitrogen’s corporate culture,” said Gregory Lucier, Chairman and CEO of Invitrogen. “It’s an essential part of our corporate philanthropy initiative and allows our employees another avenue of giving back to the communities in which they live and work.”

About Invitrogen

Invitrogen Corporation (NASDAQ:IVGN - News) provides products and services that support academic and government research institutions and pharmaceutical and biotech companies worldwide in their efforts to improve the human condition. The company provides essential life science technologies for disease research, drug discovery, and commercial bioproduction. Invitrogen’s own research and development efforts are focused on breakthrough innovation in all major areas of biological discovery including functional genomics, proteomics, stem cells, cell therapy and cell biology — placing Invitrogen’s products in nearly every major laboratory in the world. Founded in 1987, Invitrogen is headquartered in Carlsbad, California, and conducts business in more than 70 countries around the world. The company employs approximately 4,700 scientists and other professionals and had revenues of approximately $1.3 billion in 2007. For more information, visit www.invitrogen.com.